Imperial College London

Dr Anne-Marie Russell

Faculty of MedicineDepartment of Surgery & Cancer

Honorary Clinical Research Fellow



a.russell Website




G08Emmanuel Kaye BuildingRoyal Brompton Campus




Peer Reviewed Journal Publications

  1. Saketkoo LA, Scholand MB, Lammi MR, Russell AM. Patient-Reported Outcome Measures in Systemic Sclerosis related Interstitial Lung Disease for Clinical Practice and Clinical Trials Journal of Scleroderma and Related Disorders JSO-20-0003 accepted Jan 2020 in press
  2. Moor C; Wijsenbeek M; Balestro E; Biondini D; Bondue B; Cottin V; Flewett R; Galvin L; Jones S; Molina-Molina, M; Prasse A; Russell AM; Viegas M; Wanke G; Wuyts W; Kreuter M; Bonella F. Gaps in care of patients living with pulmonary fibrosis: An Expert Statement on the results of a Europe-wide survey ERJ Open Research  2019 5: 00124-2 DOI:10.1183/23120541.00124-2019
  3. Visca D, Mori L, Tsipouri V, Fleming S, Firouzi A, Bonini M, Pavitt MJ, Alfieri V, Canu S, Bonifazi M, Boccabella C, De Lauretis A, Stock CJW, Saunders P, Montgomery A, Hogben C, Stockford A, Pittet M, Brown J, Chua F, George PM, Molyneaux PL, Margaritopoulos GA, Kokosi M, Kouranos V, Russell AM, Birring SS, Chetta A, Maher TM, Cullinan P, Hopkinson NS, Banya W, Whitty JA, Adamali H, Spencer LG, Farquhar M, Sestini P, Wells AU, Renzoni EA. Effect of Ambulatory Oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a randomised mixed-method cross-over controlled clinical trial Aug 2018 The Lancet Respiratory Medicine 2018 Oct;6(10):759-770. doi: 10.1016/S2213-2600(18)30289-3. Epub 2018
  4. Newell K, Smith K, Russell AM Palliative and end of life care in idiopathic pulmonary fibrosis. J Primary Health Care 2018. doi: 10.7748/phc.2018.e1387
  5. Saketkoo LA, Karpinski A, Young J, Adell R, Walker M, Hennebury T, Wickremasinghe M, Russell AM Feasibility, Utility and Symptom Impact of Modified Mindfulness Training (MT) in Sarcoidosis Research Letter ERJ Open Research Apr 2018, 4 (2) 00085-2017; DOI: 10.1183/23120541.00085-2017
  6. Russell AM; Lines S; Olive S; Murphy A; Hocking J; Newell K; Morris H; Harris E; Dixon C; Agnew S; Burge G Contemporary Challenges For Specialist Nursing In Interstitial Lung Disease. ERJ Breathe 14 (1) 36; 10.1183/20734735.014917.
  7. Maher TM, Eunice Oballa E, Simpson J, Porte J, Habgood A, Fahy WA, Flynn A, Molyneaux PM, Braybrooke R, Divyateja H Parfrey H, Rassl D, Russell AM, Saini G, Renzoni EA, Duggan AM, Hubbard R, Wells AU, Lukey PT, Marshall RP, Jenkins G. Identification of an epithelial biomarker signature in Idiopathic Pulmonary Fibrosis: analysis from the prospective multicentre PROFILE study. The Lancet Respiratory Medicine ePub Nov 14, 2017
  8. Kreuter M*, Bendstrup E*, Russell AM*, Bajwah S, Lindell K, Adir Y, Brown CE, Calligaro G, Cassidy N, Corte TJ, Geissler K, Hassan AA, Kerri Johansson K, Kairalla R, Kolb M, Kondoh Y, Quadrelli S, Swigris JJ, Udwadia Z, Wells AU, Wijsenbeek M Palliative Care In ILD: Living Well The Lancet Respiratory Medicine 14/10/2017 DOI: 10.1016/S2213-2600(17)30383-1 (*joint authorship)
  9. Van Manen MJ, Birring S, Vancheri C, Vindigni V, Renzoni E, Russell AM, Wapenaar M, Cottin V, Wijsenbeek MS Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis. Research Letter Eur Respir J. 2017 50: 1701157; DOI: 10.1183/13993003.01157-2017
  10. Maher TM, Molina-Molina M, Russell AM, Bonella F, Jouneau S, Ripamonti E, Axmann J, Vancheri C Unmet needs in the treatment of idiopathic pulmonary fibrosis―insights from patient chart review in five European countries BMC Pulmonary Medicine 2017; 17(1) DOI: 10.1186/s12890-017-0468-5
  11. Spruit MA, Burtin C, Langer D, Makonga J, Russell AM, Yorke J, Steenbruggen I: Assembly 9: allied respiratory professionals. Breathe 2016 12: e113-14; DOI:10.1183/20734735.019216
  12. Lewis A, Cave P Stern M, Welch L, Taylor K, Russell J, Russell AM, Doyle AM, McKee H, Clift S, Bott J, Hopkinson NS. Singing for Lung Health – a systematic review of the literature and consensus statement. npj Primary Care Respir Med 16080; 2016 DOI:10.1038/npjpcrm.2016.80
  13. Russell AM, Maher TM Response: ‘Daily home spirometry: A New Milestone in the field of Pulmonary Fibrosis’ In: Am J Respir Critical Care Med 194(8): 1034 Oct 2016 DOI: 10.1164/ rccm.201606-1238LE
  14. Van Manen MJ, Birring S, Vancheri C, Cottin V, Renzoni E, Russell AM, Wijsenbeek MS: Cough in IPF Eur Respir Rev 25 (141): 278-286; Sept 2016 DOI:10.1183/16000617.0090-2015
  15. Russell AM, Swigris JJ What is it like to live with IPF? Ask the Experts. Editorial Eur Respir J May 2016, 47 (5) 1324-1326; DOI: 10.1183/13993003.00109-2016
  16. Russell AM, Adamali H, Molyneaux PL, Marshall RP, Lukey PT, Renzoni EA, Wells AU, Maher TM. Daily home spirometry: an effective tool for detecting progression in idiopathic pulmonary fibrosis. Am J Respir & Critical Care Med. 2016;194(8):989-997. doi:10.1164/rccm.201511-2152OC.
  17. Russell AM, Ripamonti E, Vancheri C: Qualitative European survey of patients with idiopathic pulmonary fibrosis: patients’ perspectives; disease & treatment. BMC Pul Medicine Jan 2016 DOI:10.1186/s12890-016-0171-y
  18. Lammi MR, Baughman RP, Birring SS, Russell AM, Ryu JH, Scholand M, Distler O, LeSage D, Sarver C, Antoniou K, Highland KB, Lasky JA, Wells AU, Saketkoo LA: Outcome Measures for Clinical Trials in Interstitial Lung Diseases. Current Respir Med Revs Nov 2015;11(2) 163-74 DOI: 10.2174/ 1573398X116 66150619183527
  19. Russell AM, Sprangers MAG, Wibberley S, Snell N, Rose DM & Swigris J: The Need for patient-centred clinical research in IPF. BMC Pulmonary Medicine Sept 2015; 13:240 DOI:10.1186/s12916-015-0475-4
  20. Russell AM Idiopathic Pulmonary Fibrosis: Care Standards & Care planning. Nurs Times; 2015 111:18, 20-25
  21. Jenkins RG, Simpson JK, Saini G, Bentley JH, Russell AM, Braybrooke R, Molyneaux PL, McKeever TM, Wells AU, Flynn A, Hubbard RB, Leeming D, Marshall R, Karsdal M, Lukey P, Maher TM Relating longitudinal change in collagen degradation biomarkers to outcome in IPF: analysis from the prospective, multi-centre PROFILE study. The Lancet Respiratory Medicine 2015; 3 (6): 462-72. DOI: 10.1016/S2213-2600(15)00048-X.2015
  22. Russell AM & Maher TM Detecting anxiety and depression in patients diagnosed with an interstitial lung disease. Can we do better? Respirology 2014; 19(8):1095-6 DOI: 10.1111/resp.12407
  23. Molyneaux PL, Cox MJ, Willis-Owen SAG, Russell AM, Mallia P, Russell KE, Murphy E, Johnston SL, Schwartz DA, Wells AU, Cookson WOC, Maher TM, Moffatt MF - Bacterial Load and Outcome in Idiopathic Pulmonary Fibrosis. Am J Respir Critical Care Med 2014; 190 (8): 906-913. DOI: 10.1164/ rccm.201403-0541OC
  24. Wuyts WA; Peccatori FA; Russell AM Patient-centred management in IPF: Similar themes in three communication models Eur Respir Rev 2014 (132):231-8 DOI: 10.1183/09059180.00001614
  25. Stock CJ, Sato H, Fonseca C, Banya W, Molyneaux PL, Adamali HI, Russell AM, Denton CP, Abraham DJ, Hansell DM, Nicholson AG, Maher TM, Wells AU, Lindahl GE, Renzoni EA “Mucin 5B promoter polymorphism associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis” Thorax 2013; 68(5):436-41. DOI: 10.1136/thoraxjnl-2012-201786
  26. Adamali HI; Anwar MS; Russell AM; Egan JJ. Non-pharmacological Treatment of Idiopathic Pulmonary Fibrosis Current Respir Care Reports 2012 1:208–215 DOI 10.1007/s13665-012-0031-z
  27. Yorke J; Swigris J; Russell, AM; Moosavi S; Ng Man Kwong G; Longshaw M; Jones P. Dyspnoea-12: A valid & reliable measure of breathlessness in patients with ILD Chest 2011; 139(1):159-64. DOI: 10.13 78/chest.10-0693

Guest Lectures

Integrated patient pathways of care in IPF: Multi-disciplinary Perspectives., Roche Europe, Helsinki, 2017

Keynote Speech: Homology of Clinical-Academic Research, Pan London Airways Network Winter Meeting, Royal College of General Practitioners | London, 2016

Patient communication strategies in IPF In: Sixth annual Advancing in IPF Research (AIR) meeting, Advancing IPF Research Faculty, Vienna / Austria, 2016